Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Ongoing clinical trials of combination immunotherapy and locoregional treatment
| Trial identifier | Agent/regional therapy | Primary endpoint | Status |
|---|---|---|---|
| NCT03143270 | Nivolumab with deb-TACE | Safety | Ongoing, recruiting |
| NCT03099564 | Pembrolizumab with Y-90 radioembolization | PFS | Ongoing, recruiting |
| NCT03482102 | Durvalumab, tremelimumab radiation therapy | ORR | Ongoing, recruiting |
PFS, progression free survival; ORR, objective response rate; deb-TACE, drug-eluting bead transarterial chemoembolization.
